Personal information

No personal information available

Activities

Collapse all

Employment (9)

Karolinska University Hospital: Stockholm, SE

(Endokrinologi och njurmedicin)
Employment
Source: check_circle
Karolinska Institutet

Karolinska Institutet: Stockholm, SE

(Department of Molecular Medicine and Surgery)
Employment
Source: check_circle
Karolinska Institutet

Karolinska Institutet: Stockholm, SE

(Department of Molecular Medicine and Surgery)
Employment
Source: check_circle
Karolinska Institutet

Academic Specialist Centre: Stockholm , SE

2020 to present | Chief physician (Centre for Diabetes )
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska University Hospital: Stockholm, SE

2016 to 2020 | Specialist in endocrinology (Department of Endocrinology, Metabolism and Diabetes)
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska University Hospital: Stockholm, Stockholm , SE

2014 to 2016 | Internship in endocrinology (Endocrinology, metabolism and diabetes )
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska Universitetssjukhuset: Stockholm, SE

2008-01-01 to 2014-12-01 | Resident in internal medicine (20% reseaech time) (Department of endocrinology, metabolism och diabetes)
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska Universitetssjukhuset: Stockholm, SE

2007-01-01 to 2007-12-31 | Medical doctor (Department of endocrinology metabolism and diabetes)
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska Universitetssjukhuset: Stockholm, SE

2003-08-01 to 2006-12-31 | Internship
Employment
Source: Self-asserted source
Neda Rajamand Ekberg

Education and qualifications (2)

Karolinska Institutet: Stockholm, SE

2001-01-21 to 2005-06-17 | PhD
Education
Source: Self-asserted source
Neda Rajamand Ekberg

Karolinska Institutet: Stockholm, SE

1994-08-17 to 2003-05-31 | Medical Doctor
Education
Source: Self-asserted source
Neda Rajamand Ekberg

Works (31)

Identification and interpretation of risk factors for Charcot foot. Reply to Milbourn VEL, Bus SA, Game F, van Netten JJ [letter]

Diabetologia
2025-02-20 | Journal article
DOI: 10.1007/s00125-025-06389-4
Contributors: Georgios Tsatsaris; Neda Rajamand Ekberg; Tove Fall; Sergiu-Bogdan Catrina
Source: check_circle
Crossref

Risk factors for Charcot foot development in individuals with diabetes mellitus

Diabetologia
2024-12 | Journal article
DOI: 10.1007/s00125-024-06271-9
Contributors: Georgios Tsatsaris; Neda Rajamand Ekberg; Tove Fall; Sergiu-Bogdan Catrina
Source: check_circle
Crossref

PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice

Diabetes Therapy
2024-09 | Journal article
DOI: 10.1007/s13300-024-01614-6
Contributors: Sergiu-Bogdan Catrina; Hanan Amadid; Uffe C. Braae; Jonatan Dereke; Neda Rajamand Ekberg; Boris Klanger; Stefan Jansson
Source: check_circle
Crossref

Smart Pen Exposes Missed Basal Insulin Injections and Reveals the Impact on Glycemic Control in Adults With Type 1 Diabetes

Journal of Diabetes Science and Technology
2024-01 | Journal article
DOI: 10.1177/19322968221104142
Contributors: Neda Rajamand Ekberg; Niels Væver Hartvig; Anne Kaas; Jonas Bech Møller; Peter Adolfsson
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Diabetes Therapy
2023-09 | Journal article
DOI: 10.1007/s13300-023-01444-y
Contributors: Marcus Lind; Sergiu-Bogdan Catrina; Neda R. Ekberg; Sofia Gerward; Tariq Halasa; Jarl Hellman; Detlef Hess; Magnus Löndahl; Veronica Qvist; Jan Bolinder
Source: check_circle
Crossref

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups

BMJ Open Diabetes Res Care
2022 | Journal article
DOI: 10.1136/bmjdrc-2021-002619
SOURCE-WORK-ID:

149321981

PMID: 35383100
Contributors: Yale, JF; Bodholdt, U; Catarig, AM; Catrina, S; Clark, A; Ekberg, NR; Erhan, U; Holmes, P; Knudsen, ST; Liutkus, J et al.
Source: check_circle
Karolinska Institutet

Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes

Elife
2022 | Journal article
DOI: 10.7554/eLife.70714
SOURCE-WORK-ID:

148918489

PMID: 35164902
Contributors: Zheng, X; Narayanan, S; Xu, C; Eliasson Angelstig, S; Grünler, J; Zhao, A; Di Toro, A; Bernardi, L; Mazzone, M; Carmeliet, P et al.
Source: check_circle
Karolinska Institutet

The Impact of Macronutrient Composition on Metabolic Regulation: An Islet-Centric View

Acta Physiol (Oxf)
2022 | Journal article
DOI: 10.1111/apha.13884
SOURCE-WORK-ID:

236056607

PMID: 36056607
Contributors: Carolo Dos Santos, K; Olofsson, C; Cunha, JPMCM; Roberts, F; Catrina, SB; Fex, M; Rajamand Ekberg, N; Spégel, P
Source: check_circle
Karolinska Institutet

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy (vol 2019, 2936962, 2019)

J. Diabetes Res.
2021 | Journal article
DOI: 10.1155/2021/9827150
SOURCE-WORK-ID:

146859852

PMID: 34124271
Contributors: Ekberg, NR; Eliasson, S; Li, YW; Zheng, XW; Chatzidionysiou, K; Falhammar, H; Gu, HF; Catrina, SB
Source: check_circle
Karolinska Institutet

Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study

Primary Care Diabetes
2021-10 | Journal article
DOI: 10.1016/j.pcd.2021.06.008
Contributors: Neda Rajamand Ekberg; Ulrik Bodholdt; Andrei-Mircea Catarig; Sergiu-Bogdan Catrina; Katrine Grau; Cecilia Nagorny Holmberg; Boris Klanger; Søren Tang Knudsen
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Effects of Acute Fructose Loading on Markers of Inflammation—A Pilot Study

Nutrients
2021-09-04 | Journal article
DOI: 10.3390/nu13093110
Contributors: Camilla Olofsson; Monica Eriksson; Ann-Christin Bragfors Helin; Björn Anderstam; Nicola Orsini; Peter Stenvinkel; Neda Rajamand Ekberg
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Human apolipoprotein CIII levels; evaluation of three assay methods

Scand. J. Clin. Lab. Invest.
2020 | Journal article
DOI: 10.1080/00365513.2020.1725976
SOURCE-WORK-ID:

143419736

PMID: 32108506
Contributors: Sandin, A; Olofsson, C; Stralfors, A; Ekberg, NR; Brismar, K; Juntti-Berggren, L; Eggertsen, G
Source: check_circle
Karolinska Institutet

HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism

Commun. Biol.
2020 | Journal article
DOI: 10.1038/s42003-020-01495-y
SOURCE-WORK-ID:

145348920

PMID: 33318569
Contributors: Narayanan, S; Angelstig, SE; Xu, C; Grunler, J; Zhao, A; Zhu, W; Landen, NX; Stahle, M; Zhang, JP; Ivan, M et al.
Source: check_circle
Karolinska Institutet

Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study

Sci Rep
2020 | Journal article
DOI: 10.1038/s41598-020-72141-0
SOURCE-WORK-ID:

144811030

PMID: 32934313
Contributors: Ekberg, NR; Falhammar, H; Naslund, E; Brismar, K
Source: check_circle
Karolinska Institutet

Effects of acute fructose loading on levels of serum uric acid-a pilot study

Eur. J. Clin. Invest.
2019 | Journal article
DOI: 10.1111/eci.13040
SOURCE-WORK-ID:

139942918

PMID: 30368775
Contributors: Olofsson, C; Anderstam, B; Bragfors-Helin, AC; Eriksson, M; Qureshi, AR; Lindholm, B; Hilding, A; Wiczkowski, W; Orsini, N; Stenvinkel, P et al.
Source: check_circle
Karolinska Institutet

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

J Diabetes Res
2019 | Journal article
DOI: 10.1155/2019/2936962
SOURCE-WORK-ID:

141015014

PMID: 31214621
Contributors: Ekberg, NR; Eliasson, S; Li, YW; Zheng, X; Chatzidionysiou, K; Falhammar, H; Gu, HF; Catrina, SB
Source: check_circle
Karolinska Institutet

Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes

Proc. Natl. Acad. Sci. U.S.A.
2019 | Journal article
DOI: 10.1073/pnas.1900351116
SOURCE-WORK-ID:

140694590

PMID: 30886104
Contributors: Zheng, X; Narayanan, S; Sunkari, VG; Eliasson, S; Botusan, IR; Grünler, J; Catrina, AI; Radtke, F; Xu, C; Zhao, A et al.
Source: check_circle
Karolinska Institutet

Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity.

2015-12 | Journal article
DOI: 10.1016/j.ghir.2015.07.009
PMID: 26283275
Contributors: Arnetz L; Hage C; Ekberg NR; Alvarsson M; Brismar K; Norhammar A; Mellbin L
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes.

2015-06 | Journal article
DOI: 10.1530/EC-15-0003
PMID: 25750212
PMC: PMC4401103
Contributors: Arnetz L; Rajamand Ekberg N; Brismar K; Alvarsson M
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Sex differences in type 2 diabetes: focus on disease course and outcomes.

2014 | Journal article
DOI: 10.2147/DMSO.S51301
PMID: 25258546
PMC: PMC4172102
Contributors: Arnetz L; Ekberg NR; Alvarsson M
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity.

2014-08 | Journal article
DOI: 10.1111/cei.12316
PMID: 24593795
Contributors: Brauner H; Lüthje P; Grünler J; Ekberg NR; Dallner G; Brismar K; Brauner A
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes.

2014-04 | Journal article
DOI: 10.1007/s00592-013-0457-y
PMID: 23389468
Contributors: Arnetz L; Dorkhan M; Alvarsson M; Brismar K; Ekberg NR
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes.

2014-04 | Journal article
DOI: 10.1007/s00592-013-0498-2
PMID: 23836328
Contributors: Du Y; Zhang H; Montano S; Hegestam J; Ekberg NR; Holmgren A; Brismar K; Ungerstedt JS
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Improved Insulin Sensitivity during Pioglitazone Treatment Is Associated with Changes in IGF-I and Cortisol Secretion in Type 2 Diabetes and Impaired Glucose Tolerance.

2013 | Journal article
DOI: 10.1155/2013/148497
PMID: 23401789
PMC: PMC3562586
Contributors: Arnetz L; Rajamand Ekberg N; Höybye C; Brismar K; Alvarsson M
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Brain metabolism and oxygenation in healthy pigs receiving hypoventilation and hyperoxia.

2013-12 | Journal article
DOI: 10.1016/j.resp.2013.08.010
PMID: 24013004
Contributors: Rostami E; Rocksén D; Ekberg NR; Goiny M; Ungerstedt U
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Gender differences in reactivity of the hypothalamic-pituitary-adrenal (HPA) axis are abolished in type 2 diabetes mellitus

Endocr. J.
2010 | Conference abstract
SOURCE-WORK-ID:

121377036
Contributors: Arnetz, LFJ; Ekberg, NR; Brismar, K; Alvarsson, M
Source: check_circle
Karolinska Institutet

Increased levels of cortisol and IGF-I after treatment with pioglitazone in patients with diabetes mellitus type 2

Endocr. J.
2010 | Conference abstract
SOURCE-WORK-ID:

121377054
Contributors: Ekberg, NR; Dorkhan, M; Arnetz, LFJ; Brismar, K
Source: check_circle
Karolinska Institutet

Analyte flux at a biomaterial-tissue interface over time: implications for sensors for type 1 and 2 diabetes mellitus.

2010-09 | Journal article
DOI: 10.1177/193229681000400505
PMID: 20920426
PMC: PMC2956810
Contributors: Ekberg NR; Brismar K; Malmstedt J; Hedblad MA; Adamson U; Ungerstedt U; Wisniewski N
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus

Diabetes Obes. Metab.
2005 | Journal article
DOI: 10.1111/j.1463-1326.2004.00424.x
SOURCE-WORK-ID:

1934023

PMID: 16050945
Contributors: Rajamand, N; Ungerstedt, U; Brismar, K
Source: check_circle
Karolinska Institutet

Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion flow rates.

2005-09 | Journal article
DOI: 10.1016/j.cccn.2005.03.033
PMID: 15939412
Contributors: Ekberg NR; Wisniewski N; Brismar K; Ungerstedt U
Source: Self-asserted source
Neda Rajamand Ekberg via Europe PubMed Central
grade
Preferred source (of 2)‎

Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats

Am. J. Physiol.-Endocrinol. Metab.
2002 | Journal article
DOI: 10.1152/ajpendo.00259.2001
SOURCE-WORK-ID:

1950876

PMID: 12006362
Contributors: Wisniewski, N; Rajamand, N; Adamsson, U; Lins, PE; Reichert, WM; Klitzman, B; Ungerstedt, U
Source: check_circle
Karolinska Institutet
How many people are using ORCID?